Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q4 2017 call → NOWe need to determine if management conveys that the business is visibly outgrowing the company's current size. Look for statements about current activity, demand, commitments being large relative to company size. The transcript mentions growth in Blackhawk, U.S. onshore TRS, etc. But does management explicitly say that what is arriving now is disproportionately large compared to the company's small size? They talk about growth, but not necessarily a disproportion. They mention "we are seeing more tenders and are winning new profitable work" but that's generic. They also mention "we have some very nice offshore rig wins that will start up for us later in the year" but that's future. They talk about cost reductions and efficiency. No explicit statement that current business is outgrowing the company's size. They mention "Blackhawk also saw meaningful improvement" but not that it's disproportionately large. The question asks for a coherent situation where the company is small and what is happening is disproportionately large. Management does not seem to convey that. They talk about growth but not in a way that suggests the current activity is large relative to the company's smallness. They also mention challenges in Q1. So answer NO. Answer: NO
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.